Tersano SAO Tested Against SARS-CoV-2 Surrogate
Tersano’s stabilized aqeous oxide (SAO™) cleaning solution has completed an initial round of independent testing against an approved surrogate for the SARS-CoV-2 virus.
The Coronavirus/MHV-3. MHV-3 (Murine coronavirus/Murine Hepatitis Virus) is an approved surrogate that belongs to the same Genus (Betacoronavirus) as SARS (SARS-CoV), MERS (MERS-CoV), and COVID-19 (SARS-CoV-2).
Tersano’s SAO solution was also tested against Influenza A Virus (H1N1), Measles Virus and Syncytial Respiratory Virus, with the manufacturer reporting it was effective in eliminating >99.99% (>4-log) of all four enveloped viruses with a one minute dwell time in a pathogen summary report.
The next stage of testing, which is expected in June, will involve SARS-CoV-2, the causative agent of COVID-19.